Skip to content

Research on the Application of Fully Convolutional Neural Network in Lesion Segmentation of Port-Wine Stain VISIA Images

Research on the Application of Fully Convolutional Neural Network in Lesion Segmentation of Port-Wine Stain VISIA Images

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103469
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bright red spots on the face

Interventions

Group of patients with facial bright erythematous nevus treated with HMME-PDT:None

Sponsors

The Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Male and female patients aged 2 to 60 years with a clear clinical diagnosis of port-wine stains; 2.The skin lesion is located on the face; 3.There are no other related diseases that cause changes in skin thickness and vascular density at the lesion site; 4.Good physical condition and no history of systemic diseases in the past; 5.The treatment area has not received isotope therapy; 6.HMME-PDT treatment is planned;

Exclusion criteria

Exclusion criteria: 1.Obvious infectious lesions can be seen at the lesion site; 2.The treatment area has physical skin diseases or allergic diseases; 3.Suffer from other types of vascular diseases; 4.People with allergic constitutions, those with a tendency to form scars or those with a tendency to form scars; 5.There is a history of intense sunlight exposure within one month; 6.Have taken photosensitive drugs or consumed a large amount of photosensitive food within one month; 7.Those whose electrocardiogram examination shows severe myocardial ischemia and underlying heart diseases that may lead to cardiac arrest; Those with severe liver diseases and impaired liver function; There is a history of hemorrhagic diseases; 8.Those who suffer from serious neurological or mental disorders; 9.Those who have a history of allergy to heimpofen photosensitizers and drugs with similar chemical structures;

Design outcomes

Primary

MeasureTime frame
VISIA Red Zone Photo;

Secondary

MeasureTime frame
Dermoscope;High-frequency skin ultrasound examination;

Countries

China

Contacts

Public ContactXiangning Qiu

The Second Xiangya Hospital, Central South University

xiangningqiu@csu.edu.cn+86 731 85292452

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026